tiprankstipranks
Trending News
More News >
RemeGen Co. Ltd. Class H (HK:9995)
:9995
Hong Kong Market
Advertisement

RemeGen Co. Ltd. Class H (9995) Similar Stocks

Compare
6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
RemeGen Co. Ltd. Class H
HK$106.20
HK$69.69B
567.09%
0 Buy
0 Hold
3 Sell
Strong Sell
Genscript Biotech
HK$17.08
$38.39B
0.97
30.86%
1 Buy
0 Hold
0 Sell
Moderate Buy
Zai Lab Ltd
HK$25.38
€29.11B
33.16%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$29.70
HK$42.93B
93.33%
1 Buy
1 Hold
1 Sell
Hold
Simcere Pharmaceutical Group Limited
HK$12.62
HK$34.52B
34.46
92.45%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$75.75
HK$43.04B
46.26
214.73%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9995
RemeGen Co. Ltd. Class H
106.20
91.28
611.80%
HK:1548
Genscript Biotech
16.75
4.27
34.21%
HK:9688
Zai Lab Ltd
25.38
6.34
33.30%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
29.58
15.14
104.85%
HK:2096
Simcere Pharmaceutical Group Limited
12.49
6.32
102.43%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
71.60
48.90
215.42%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis